Northwest Investment Counselors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$16.3K Buy
+247
New +$17.9K ﹤0.01% 378
2024
Q2
Sell
-142
Closed -$13.6K 256
2024
Q1
$13.6K Buy
+142
New +$11.9K ﹤0.01% 350
2023
Q4
Sell
-1,061
Closed -$73.5K 257
2023
Q3
$73.5K Buy
1,061
+52
+5% +$4.18K 0.02% 193
2023
Q2
$95.2K Hold
1,009
0.03% 184
2023
Q1
$83.5K Sell
1,009
-131
-11% -$10.3K 0.02% 197
2022
Q4
$85.1K Buy
1,140
+1,050
+1,167% +$80.9K 0.02% 197
2022
Q3
$7K Sell
90
-123
-58% -$11.8K ﹤0.01% 402
2022
Q2
$20K Hold
213
0.01% 298
2022
Q1
$25K Sell
213
-21
-9% -$2.36K 0.01% 293
2021
Q4
$30K Buy
+234
New +$27.3K 0.01% 277
2021
Q2
Sell
-234
Closed -$20K 234
2021
Q1
$20K Buy
+234
New +$19.8K 0.01% 300
2020
Q4
Sell
-234
Closed -$19K 233
2020
Q3
$19K Buy
+234
New +$18.3K 0.01% 274
2019
Q4
Sell
-66
Closed -$5K 259
2019
Q3
$5K Buy
+66
New +$4.64K ﹤0.01% 430

Other funds holding EW

Northwest Investment Counselors's EW Position: Q3 2024 in Review

Northwest Investment Counselors opened a new position in Edwards Lifesciences (EW) in Q3 2024: 247 shares worth $16.3K. The stake represents ﹤0.01% of the portfolio and ranks #378 among its holdings. This is a return to the name: Northwest Investment Counselors previously reported a position in EW as recently as Q1 2024.

Northwest Investment Counselors first reported a position in EW in Q3 2019 and has held it in 13 quarters since. The position peaked at $95.2K in Q2 2023. 1,194 funds tracked by Wall St. Rank hold EW as of Q3 2024.

  • Northwest Investment Counselors held 247 shares of Edwards Lifesciences worth $16.3K as of Q3 2024.
  • Edwards Lifesciences was a new Northwest Investment Counselors position in Q3 2024.
  • Edwards Lifesciences made up ﹤0.01% of Northwest Investment Counselors's portfolio in Q3 2024, its #378 holding.
  • Northwest Investment Counselors first reported a position in Edwards Lifesciences in Q3 2019 and has held it in 13 quarters since.
  • Northwest Investment Counselors's Edwards Lifesciences position peaked at $95.2K in Q2 2023.
  • 1,194 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.

Based on Northwest Investment Counselors's 13F filing for Q3 2024, filed 21 Oct 2024.